Owens & Minor (OMI)
(Delayed Data from NYSE)
$11.80 USD
-0.20 (-1.67%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $11.51 -0.29 (-2.46%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.80 USD
-0.20 (-1.67%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $11.51 -0.29 (-2.46%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth B Momentum A VGM
Zacks News
Top Ranked Growth Stocks to Buy for March 15th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 15th
Buy These 5 Low-Beta Stocks & Combat the Choppy Market
by Nilanjan Banerjee
Low-beta stocks may be able to help sail through the choppy market conditions.
Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio
by Zacks Equity Research
Investors remain optimistic about Bio-Rad (BIO) backed by strong segmental performance across geographies and robust testing portfolio.
Earnings Estimates Rising for Owens & Minor (OMI): Will It Gain?
by Zacks Equity Research
Owens & Minor (OMI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Top Ranked Growth Stocks to Buy for March 9th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 9th
Abbott's (ABT) Diagnostics Arm to Gain From New & Updated EUAs
by Zacks Equity Research
Abbott's (ABT) Alinity m SARS-CoV-2 test set to detect COVID-19 in individuals who do not have symptoms.
Boston Scientific (BSX) Buys Lumenis to Expand in Urology
by Zacks Equity Research
The transaction is expected to remain immaterial to Boston Scientific's (BSX) 2021 adjusted earnings per share.
Abbott (ABT) Gets Canadian Nod for FreeStyle Libre Expanded Use
by Zacks Equity Research
Abbott's (ABT) FreeStyle Libre is the only glucose sensing technology available in Canada to remotely monitor glucose status in an expectant mother to reduce exposure to COVID-19.
Top Ranked Growth Stocks to Buy for March 3rd
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 3rd
Zacks.com featured highlights include: Owens & Minor, Sturm Ruger & Company, Natus Medical, Penumbra and Toyota Motor
by Zacks Equity Research
Zacks.com featured highlights include: Owens & Minor, Sturm Ruger & Company, Natus Medical, Penumbra and Toyota Motor
Medtronic's (MDT) Market Share Grows Amid COVID-19 Woes
by Zacks Equity Research
In Coronary, the ongoing issue related to the China drug-eluting stent national tender, Medtronic (MDT) is currently winning share globally.
Thermo Fisher (TMO) Buys Mesa Biotech, Grows in Point of Care
by Zacks Equity Research
Mesa Biotech's point-of-care platform is likely to help Thermo Fisher (TMO) rapidly scale up manufacturing volume amid the pandemic.
Top Ranked Growth Stocks to Buy for March 1st
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 1st
New Strong Buy Stocks for March 1st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.
Buy These 5 Low-Beta Stocks to Beat the Choppy Market
by Nilanjan Banerjee
To combat the choppy market conditions, it is of utmost importance to create a portfolio of low-beta stocks.
NuVasive (NUVA) Boosts Cervical Portfolio With New Buyout
by Zacks Equity Research
NuVasive (NUVA) expands comprehensive portfolio of C360 with the addition of Simplify Disc.
Owens & Minor (OMI) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Owens & Minor (OMI) delivered earnings and revenue surprises of 32.56% and 8.97%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Owens & Minor (OMI) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
We expect the strength in demand for Owens & Minor's (OMI) PPEs to have continued through the fourth quarter.
Owens & Minor (OMI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Owens & Minor (OMI) closed at $27.37, marking a +0.11% move from the previous day.
Why the Earnings Surprise Streak Could Continue for Owens & Minor (OMI)
by Zacks Equity Research
Owens & Minor (OMI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Owens & Minor (OMI) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Owens & Minor (OMI) closed the most recent trading day at $29.08, moving -1.79% from the previous trading session.
Owens & Minor (OMI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Owens & Minor (OMI) closed at $26.97 in the latest trading session, marking a +0.33% move from the prior day.
Top Ranked Growth Stocks to Buy for January 13th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 13th.
Neogen (NEOG) Launches Dairy Toxin Detection Test Reveal Q+
by Zacks Equity Research
Neogen's (NEOG) new test can detect cancer causing aflatoxin M1 in milk within a range of 150-600 parts per trillion (ppt).
Top Ranked Growth Stocks to Buy for January 12th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 12th.